Factor V Level Test at Lahore PCR Lab

Introduction to Factor V Level at Lahore PCR Lab

Coagulation is a highly complex and finely tuned physiological process that prevents excessive bleeding following vascular injury. Among the essential proteins driving this process is Factor V (also known as proaccelerin or labile factor), a critical protein cofactor synthesized primarily in the liver and stored in both blood plasma and platelet alpha-granules. Factor V plays a pivotal role in the common pathway of the coagulation cascade. Once activated by thrombin, active Factor V (Factor Va) binds with activated Factor X (Factor Xa), calcium ions, and phospholipid surfaces to form the prothrombinase complex. This vital complex accelerates the conversion of prothrombin (Factor II) into thrombin (Factor IIa) by several thousand-fold, ultimately leading to the formation of a stable fibrin clot. A deficiency or dysfunction in this clotting factor can lead to severe bleeding disorders, while specific genetic mutations can result in life-threatening hypercoagulable states.

Lahore PCR Lab, a premier diagnostic and molecular testing facility located in Lahore, Pakistan, offers comprehensive and highly precise Factor V testing. Utilizing state-of-the-art automated coagulometers and advanced molecular diagnostic technologies, Lahore PCR Lab provides both quantitative Factor V activity assays and qualitative genetic testing (such as for the Factor V Leiden mutation). This dual capability allows clinical pathologists and hematologists to accurately evaluate patients presenting with unexplained bleeding, abnormal routine coagulation screens, or recurrent thrombotic events. Understanding your Factor V level is essential for establishing an accurate diagnosis, guiding therapeutic interventions, and managing long-term cardiovascular and hematological health.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is critical to ensure the clinical accuracy and reproducibility of coagulation assays. When scheduling a Factor V Level test at Lahore PCR Lab, patients should adhere to the following preparation guidelines:

• Medication Disclosure: It is absolutely vital to inform your prescribing physician and the laboratory staff of all medications you are currently taking. Anticoagulants, including heparin, warfarin (Coumadin), direct oral anticoagulants (DOACs) like rivaroxaban or apixaban, and antiplatelet agents, can significantly interfere with clotting-based assays. Your physician may advise you to temporarily discontinue these medications prior to blood collection, though you should never stop taking prescribed medicine without direct medical supervision.
• Fasting Requirements: While a strict overnight fast is generally not required for a standalone Factor V activity test, patients are advised to avoid high-fat meals for at least 4 to 6 hours before the blood draw. Lipemic (fat-heavy) blood samples can interfere with the optical detection systems used in automated coagulometers, potentially compromising the test results.
• Hydration: Staying well-hydrated by drinking plenty of water is highly recommended. Adequate hydration makes venipuncture easier and ensures a smooth blood draw, minimizing the risk of hemolysis (rupture of red blood cells), which can invalidate coagulation test results.
• Avoid Physical Stress: Patients should avoid strenuous physical exercise and acute physical stress immediately before the test, as intense physical exertion can transiently elevate certain clotting factors and alter baseline coagulation activity.

During the Procedure

The collection of a blood sample for a Factor V Level test at Lahore PCR Lab is a standard, safe, and routine venipuncture procedure performed by highly trained phlebotomists. The entire process is completed within a few minutes and involves the following steps:

• Patient Identification and Positioning: The phlebotomist will verify your identity using standard protocols. You will be asked to sit comfortably in a blood collection chair, and your arm will be positioned to expose the antecubital fossa (the crease of the elbow).
• Vein Selection and Sanitization: A tourniquet will be applied to your upper arm to make the veins more visible and accessible. The phlebotomist will palpate the area to select a suitable vein and then thoroughly sanitize the skin using an alcohol swab or an appropriate antiseptic solution to prevent contamination.
• Sample Collection: A sterile, single-use needle will be gently inserted into the selected vein. For coagulation testing, blood must be collected into a specific light blue-top tube containing buffered sodium citrate (usually 3.2%). The sodium citrate acts as a reversible anticoagulant by chelating calcium, preserving the clotting factors in an inactive state until testing begins. It is clinically critical that the tube is filled completely to the designated fill line to maintain the precise 9:1 ratio of blood to anticoagulant; underfilled tubes will yield inaccurate, prolonged clotting times and must be rejected by the laboratory.
• Post-Collection Care: Once the required volume of blood is collected, the needle is gently withdrawn, and immediate pressure is applied to the puncture site with a sterile gauze pad to stop any bleeding. A small bandage will be applied. The phlebotomist will immediately invert the tube gently 3 to 4 times to ensure thorough mixing of the blood with the sodium citrate anticoagulant.
• Processing and Safety: The sample is promptly sent to the laboratory department, where it undergoes centrifugation to separate the cells and obtain platelet-poor plasma. This plasma is then analyzed using advanced automated coagulation analyzers. The procedure carries minimal risks, which are limited to mild, temporary discomfort at the needle insertion site, minor bruising, or very rarely, localized infection or lightheadedness.

When is a Factor V Level Test Performed?

Investigation of Unexplained Bleeding Disorders

Physicians frequently request a Factor V Level test when a patient presents with unexplained, recurrent, or severe bleeding episodes. These symptoms may include frequent and prolonged nosebleeds (epistaxis), easy bruising (ecchymosis) without significant trauma, bleeding gums, unusually heavy or prolonged menstrual periods (menorrhagia), or excessive bleeding following minor surgical procedures, dental extractions, or minor trauma. By measuring the functional activity of Factor V, hematologists can determine if a deficiency in this specific cofactor is the underlying cause of the patient’s impaired hemostasis, allowing for targeted therapeutic planning.

Evaluation of Abnormal Coagulation Profiles

A Factor V Level test is highly indicated when routine coagulation screening tests, such as Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT), yield abnormally prolonged results. Because Factor V operates within the common pathway of the coagulation cascade, a deficiency or inhibition of Factor V will prolong both the PT and the aPTT. When a patient exhibits these dual abnormalities, a systematic factor assay panel, including a quantitative Factor V activity test, is performed to isolate the specific factor deficiency and differentiate it from deficiencies in Factors II, X, or fibrinogen.

Diagnosis of Congenital or Acquired Factor V Deficiency

The test is essential for diagnosing both congenital and acquired forms of Factor V deficiency. Congenital Factor V deficiency (historically known as Owren’s disease) is an extremely rare autosomal recessive bleeding disorder. Patients with this inherited condition require precise quantification of their Factor V levels to assess the severity of their disease and guide prophylactic or on-demand treatment. Acquired Factor V deficiency, which is more common, can occur due to severe liver disease, disseminated intravascular coagulation (DIC), or the development of specific autoantibodies (inhibitors) against Factor V, all of which require accurate laboratory evaluation.

Assessment of Liver Disease and Synthetic Function

Because the liver is the primary site of synthesis for Factor V, measuring its activity is an exceptionally sensitive method for evaluating hepatic synthetic function. Unlike several other clotting factors (such as Factors II, VII, IX, and X), Factor V synthesis is not dependent on Vitamin K. Therefore, measuring Factor V levels in patients with liver disease helps clinicians differentiate between severe hepatocellular dysfunction (where Factor V is significantly reduced) and Vitamin K deficiency (where Factor V levels remain normal while Vitamin K-dependent factors are decreased). This distinction is vital for managing patients with cirrhosis, hepatitis, or acute liver failure.

Screening for Thrombophilia and Factor V Leiden Mutation

While a quantitative Factor V level test measures the functional activity or amount of the protein, molecular testing at Lahore PCR Lab is performed to identify the Factor V Leiden mutation. This genetic mutation alters the structure of the Factor V protein, making it resistant to inactivation by activated protein C (APC). This resistance leads to a hypercoagulable state (thrombophilia), significantly increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). Clinicians order this molecular evaluation for patients with a personal or strong family history of recurrent, unexplained blood clots, clots occurring at an early age, or recurrent pregnancy loss.

What Does a Factor V Level Test Detect?

The Factor V Level test is highly diagnostic and can detect a wide range of clinical conditions, including:

• Severe Congenital Factor V Deficiency: Characterized by Factor V activity levels below 10% of normal, leading to significant bleeding risks.
• Mild to Moderate Congenital Deficiency: Activity levels between 10% and 50% of normal, which may cause mild bleeding symptoms or only manifest during surgery or trauma.
• Acquired Factor V Deficiency due to Liver Cirrhosis: Reduced synthetic capacity of the liver resulting in decreased circulating Factor V.
• Acute Liver Failure: A rapid, severe decline in Factor V levels, serving as an important prognostic marker for hepatic encephalopathy and survival.
• Disseminated Intravascular Coagulation (DIC): Consumption of Factor V along with other clotting factors and platelets during widespread systemic coagulation.
• Presence of Specific Factor V Inhibitors: Autoantibodies that neutralize Factor V activity, often arising spontaneously, post-operatively, or after exposure to bovine thrombin.
• Normal Coagulation Status: Factor V activity within the established reference range (typically 60% to 140%), ruling out Factor V deficiency as a cause of bleeding.
• Vitamin K Deficiency Differentiation: Normal Factor V levels in the presence of prolonged PT and aPTT, pointing toward a selective Vitamin K deficiency rather than liver failure.
• Combined Factor V and Factor VIII Deficiency: A distinct, rare autosomal recessive disorder characterized by moderately low levels of both clotting factors.
• Dilutional Coagulopathy: Reduced Factor V levels resulting from massive blood transfusions or fluid resuscitation without adequate replacement of clotting factors.
• Factor V Leiden Mutation (via PCR): The presence of the G1691A genetic mutation, confirming a hereditary predisposition to venous thromboembolism.
• Activated Protein C (APC) Resistance: Functional resistance of Factor V to cleavage by APC, highly suggestive of the Factor V Leiden mutation.
• Increased Thrombotic Risk: Elevated Factor V activity levels (above 140%), which may contribute to a mild hypercoagulable state.
• Post-operative Coagulation Changes: Transient alterations in Factor V levels following major surgical procedures.
• Neonatal Physiological Variations: Lower baseline levels of Factor V in healthy newborns, which gradually reach adult levels within the first few months of life.
• Pregnancy-Induced Hypercoagulability: Physiological increases in Factor V and other coagulation factors during pregnancy, which must be interpreted using pregnancy-specific reference ranges.
• Myeloproliferative Neoplasms: Associated alterations in coagulation factor levels and platelet function.
• Amyloidosis-Associated Deficiency: Rare cases where amyloid fibrils adsorb clotting factors, including Factor V, leading to acquired deficiency.
• Autoimmune-Induced Coagulopathy: Secondary to systemic lupus erythematosus or other autoimmune diseases that trigger transient or persistent inhibitors.
• Exogenous Estrogen Effects: Mild elevations in Factor V activity associated with oral contraceptive use or hormone replacement therapy.
• Response to Anticoagulation Therapy: Monitoring baseline coagulation status before initiating long-term anticoagulant regimens.

Turnaround Time and Report Access at Lahore PCR Lab

Lahore PCR Lab is committed to providing rapid, accurate, and highly reliable diagnostic results. For a specialized coagulation test like the Factor V Level, the laboratory employs advanced automated systems to ensure a swift turnaround time. Typically, routine Factor V activity assay results are available within 24 to 48 hours of sample collection. If molecular testing for the Factor V Leiden mutation is performed, the turnaround time may range from 3 to 5 working days due to the complex nature of DNA extraction and polymerase chain reaction (PCR) amplification.

Patients and referring physicians can access reports easily through Lahore PCR Lab’s secure online portal. Once the clinical pathologist signs off on the verified results, an automated SMS notification containing a direct, secure link is sent to the patient’s registered mobile number. Reports can be viewed, downloaded, and printed directly from the website. Additionally, physical copies of the reports can be collected from the main laboratory reception or any of its designated collection centers across Lahore. This seamless reporting process ensures that critical clinical decisions can be made without unnecessary delays.

Factor V Level Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Factor V Activity Level	60% to 140% of normal activity	Decreased (<60%) in congenital deficiency, liver disease, DIC, or in the presence of inhibitors; Elevated (>140%) in acute phase reactions or pregnancy.
Factor V Antigen Level	60% to 140% antigen concentration	Decreased in quantitative deficiencies (Type I); Normal or near-normal in qualitative defects (Type II) where protein is present but dysfunctional.
Prothrombin Time (PT)	11.0 to 13.5 seconds	Prolonged in moderate to severe Factor V deficiency, as Factor V is essential for the common pathway.
Activated Partial Thromboplastin Time (aPTT)	25.0 to 35.0 seconds	Prolonged in moderate to severe Factor V deficiency due to its role in the intrinsic/common pathway amplification.
Factor V Leiden Mutation (PCR)	Negative (Wild-type genotype)	Heterozygous (one mutated allele) or Homozygous (two mutated alleles) for the G1691A mutation, indicating thrombophilia.
Activated Protein C (APC) Resistance Ratio	Ratio > 2.0	Ratio < 2.0, indicating functional resistance to APC, highly correlated with the Factor V Leiden mutation.
Factor V Inhibitor Assay (Bethesda Unit)	No inhibitor detected (0 Bethesda Units)	Presence of neutralizing autoantibodies (measured in Bethesda Units), causing acquired Factor V deficiency.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for Factor V Level?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified clinical pathologists, hematologists, and molecular biologists with extensive experience in coagulation and genetic diagnostics.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process, from phlebotomy to report delivery.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict internal and external quality control protocols, ensuring international standards of accuracy and reproducibility.
• Professional Reporting: Every Factor V report is meticulously reviewed and signed off by a consultant pathologist, providing clear, actionable clinical insights.
• Modern Diagnostic Approach: We utilize state-of-the-art automated coagulometers and advanced PCR technology to deliver highly precise quantitative and qualitative results.
• Comfortable Environment: Our modern, hygienic, and well-designed collection centers in Lahore provide a stress-free and welcoming environment for patients.
• Convenient Location: Located centrally in Lahore, our main facility and numerous collection points offer easy accessibility for patients across the city.
• Commitment to Accurate Diagnosis: We are dedicated to supporting physicians with reliable diagnostic data, enabling timely and effective clinical management of bleeding and clotting disorders.